Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2011: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2010: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2009: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
|
Research Abstract |
miR-34b was found to have promoter hypermethylation, which when reversed, restored miR-34b expression in the endometrial serous cancer (ESC)cell lines treated with 5-aza-2' deoxycytidine. miR-34b transfection inhibited ESC cell growth, migration and most notably invasion. These effects were mediated by miR-34b target gene, the mesenchymal epithelial transition factor (MET). The expression of MET was reduced following the restoration of miR-34b in ESC cell lines. In summary, our data suggest that miR-34b plays a role in the molecular pathogenesis of endometrial cancer.
|